Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Vox Sanguinis
|
May 21, 2024
E-learning in transfusion medicine: An exploratory qualitative assessment
Arwa Z Al-Riyami, Kyle Jensen, Cynthia So-Osman, et al.
JMIR Nursing
|
July 15, 2022
Acceptability of an mHealth Family Self-management Intervention (myFAMI) for Pediatric Transplantation Families: Qualitative Focus
Stacee Marie Lerret, Erin Flynn, Rosemary White-Traut, et al.
The Journal of Pediatrics
|
February 2, 2023
Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study
Zachary J Kastenberg, Mark R Deneau, Elizabeth A O'Brien, et al.
Vox Sanguinis
|
February 19, 2025
Understanding community perspectives for advancing inclusion of trans and gender-diverse people in blood donation in Australia
Rachel Thorpe, Kyle Jensen, Barbara Masser, et al.
Journal of Pediatric Surgery
|
March 2, 2025
The Age-stratified Cost of Biliary Atresia: A MarketScan®-Based Cost Analysis
Anastasia M Kahan, Anna Gongjoo Holley, Joshua Horns, et al.
Scientific Reports
|
June 27, 2022
Transverse oscillating bubble enhanced laser-driven betatron X-ray radiation generation
Rafal Rakowski, Ping Zhang, Kyle Jensen, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 11, 2024
The association of human milk intake and outcomes in biliary atresia
Mary Elizabeth M Tessier, Jeremy M Schraw, Stacey Beer, et al.
The Journal of Surgical Research
|
May 13, 2023
Utilization of Segmental Grafts Is Associated With Higher Transplant Rates in Pediatric Patients
Fidel Lopez-Verdugo, Jorge Sanchez-Garcia, Shanni Baraki, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2026
A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia
Marina Konopleva, Vijaya Raj Bhatt, Ioannis Mantzaris, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
April 21, 2016
Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning
Kinjal Sanghavi, Anthony Wiseman, Mark N Kirstein, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Vox Sanguinis
|
May 21, 2024
E-learning in transfusion medicine: An exploratory qualitative assessment
Arwa Z Al-Riyami, Kyle Jensen, Cynthia So-Osman, et al.
JMIR Nursing
|
July 15, 2022
Acceptability of an mHealth Family Self-management Intervention (myFAMI) for Pediatric Transplantation Families: Qualitative Focus
Stacee Marie Lerret, Erin Flynn, Rosemary White-Traut, et al.
The Journal of Pediatrics
|
February 2, 2023
Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study
Zachary J Kastenberg, Mark R Deneau, Elizabeth A O'Brien, et al.
Vox Sanguinis
|
February 19, 2025
Understanding community perspectives for advancing inclusion of trans and gender-diverse people in blood donation in Australia
Rachel Thorpe, Kyle Jensen, Barbara Masser, et al.
Journal of Pediatric Surgery
|
March 2, 2025
The Age-stratified Cost of Biliary Atresia: A MarketScan®-Based Cost Analysis
Anastasia M Kahan, Anna Gongjoo Holley, Joshua Horns, et al.
Scientific Reports
|
June 27, 2022
Transverse oscillating bubble enhanced laser-driven betatron X-ray radiation generation
Rafal Rakowski, Ping Zhang, Kyle Jensen, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 11, 2024
The association of human milk intake and outcomes in biliary atresia
Mary Elizabeth M Tessier, Jeremy M Schraw, Stacey Beer, et al.
The Journal of Surgical Research
|
May 13, 2023
Utilization of Segmental Grafts Is Associated With Higher Transplant Rates in Pediatric Patients
Fidel Lopez-Verdugo, Jorge Sanchez-Garcia, Shanni Baraki, et al.
Cancer Immunology, Immunotherapy : CII
|
April 10, 2026
A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia
Marina Konopleva, Vijaya Raj Bhatt, Ioannis Mantzaris, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
April 21, 2016
Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning
Kinjal Sanghavi, Anthony Wiseman, Mark N Kirstein, et al.
Page
of 7